While Intel grapples with supply constraints and valuation concerns, rival AMD is capitalizing on the AI boom with aggressive product roadmaps and surging market share, positioning itself for sustained long-term growth.
Axis Capital (AXS) reported robust 2025 results, marked by record premiums and its best underwriting performance in over a decade. While outlining a confident growth trajectory, executives struck a cautious note on cyber insurance and reinsurance headwinds for the coming year.
Axos Financial (NYSE: AX) reported strong fiscal Q2 2026 results, with net income jumping to $128.4 million. Driven by broad-based loan growth and contributions from Verdant Commercial Capital, the digital bank highlighted expanding margins, improved credit metrics, and a confident outlook for continued mid-teens annual loan growth.
Arthur J. Gallagher & Co. reported robust fourth-quarter results, driven by a potent mix of organic expansion and strategic acquisitions like AssuredPartners. Management projects sustained mid-single-digit growth for 2026, backed by a significant capital reserve for further mergers and acquisitions.
The technology-focused lender reported solid 2025 earnings, highlighted accelerating deposit inflows and a strategic shift away from its legacy SBA portfolio. Management forecasts continued growth for 2026, banking on its digital offerings and a key securitization success.
Despite a soft first quarter, Beazer Homes executives outline a clear strategy to drive full-year EBITDA and book value growth, citing improving buyer traffic, cost-cutting initiatives, and a strategic shift toward higher-margin, solar-included communities.
Arthur J. Gallagher & Co. reported robust fourth-quarter and full-year 2025 results, driven by a dual organic and acquisition growth strategy. The insurance broker sees continued momentum into 2026, navigating a mixed pricing environment and leveraging its recent mega-merger with Assured Partners.
Amidst a backdrop of economic recalibration in Japan and cautious optimism in China, select Asian tech firms are leveraging innovation to defy market volatility. We analyze three companies—from gaming to IoT—with the fundamentals to outperform in the year ahead.
Packaging giant Ball Corporation (NYSE: BALL) is scheduled to release its quarterly earnings before Tuesday's market open. Investors are watching for signs of sustained growth as the industry navigates shifting demand and cost pressures.
InterDigital (NASDAQ: IDCC) has laid out an ambitious financial roadmap for fiscal year 2026, forecasting revenues up to $775 million. The outlook is supported by a newly inked licensing agreement with LG Electronics and a key smartphone renewal, signaling strong momentum in its patent portfolio.
Following a period of strong sales growth, Chili's Grill & Bar is laying the groundwork to potentially grant its general managers a greater ownership stake, a move inspired by industry leaders like Texas Roadhouse and Raising Cane's.
Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy, raising its price target to $142. The firm highlights the company's pivotal role in next-generation cancer treatments, including immuno-oncology and antibody-drug conjugates (ADCs), as a major catalyst for future growth.
Amid market volatility, Mettler-Toledo International Inc. (MTD) continues to draw bullish attention for its entrenched role in mission-critical measurement technology across life sciences and industrial sectors. Analysts argue its premium valuation reflects durable competitive advantages rather than market froth.
Lumentum Holdings Inc. has transformed from a consumer electronics supplier into a key player in AI infrastructure, driving a V-shaped recovery. While surging demand for high-speed optical modules paints a bullish picture, its premium valuation demands scrutiny.
A detailed analysis of Alcon Inc. (ALC) highlights the company's market leadership, margin expansion potential, and the upcoming catalyst of its UNITY surgical system, presenting a compelling bull case for the eye care specialist.
Premier Investments (ASX:PMV) faces investor scrutiny as its return on capital employed (ROCE) remains stagnant while its capital base shrinks, raising questions about its long-term compounding potential.
As the healthcare industry accelerates its shift to value-based care, Privia Health Group's physician-enablement platform is drawing investor attention for its scalable, asset-light approach and strong financial profile, with some analysts seeing significant upside potential.
SiTime Corporation (NASDAQ: SITM), a leader in MEMS-based timing solutions, is attracting bullish attention as its technology becomes increasingly critical for AI infrastructure and high-performance computing. With strong recent financials and strategic expansion, the company is navigating both opportunities and risks in a complex semiconductor landscape.
Amidst a strategic merger with New Gold and a multi-year production expansion plan, Coeur Mining emerges as a compelling North American precious metals play. Analysts point to a significant gap between its current market valuation and underlying fundamentals.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
